Valsartan 80mg capsules

Држава: Велика Британија

Језик: Енглески

Извор: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активни састојак:

Valsartan

Доступно од:

Arrow Generics Ltd

АТЦ код:

C09CA03

INN (Међународно име):

Valsartan

Дозирање:

80mg

Фармацеутски облик:

Capsule

Пут администрације:

Oral

Класа:

No Controlled Drug Status

Тип рецептора:

Valid as a prescribable product

Резиме производа:

BNF: 02050502; GTIN: 5060034834502

Информативни летак

VALSARTAN 40MG, 80MG AND 160MG CAPSULES
PACKAGE LEAFLET: INFORMATION FOR THE USER
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or
pharmacist.
• This medicine has been prescribed for you only. Do
not pass it on to others. It may harm them, even if their
signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects not
listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1
WHAT VALSARTAN CAPSULES ARE AND WHAT THEY ARE USED
FOR
2
WHAT YOU NEED TO KNOW BEFORE YOU TAKE VALSARTAN
CAPSULES
3
HOW TO TAKE VALSARTAN CAPSULES
4
POSSIBLE SIDE EFFECTS
5
HOW TO STORE VALSARTAN CAPSULES
6
CONTENTS OF THE PACK AND OTHER INFORMATION
1 WHAT VALSARTAN CAPSULES ARE AND WHAT THEY ARE USED
FOR
Valsartan Capsules contain the active substance valsartan and
belongs to a class of medicines known as angiotensin II receptor
antagonists, which help to control high blood pressure. Angiotensin
II is a substance in the body that causes the blood vessels to
tighten, causing your blood pressure to increase.
Valsartan Capsules work by blocking the effect of angiotensin II. As
a result, blood vessels relax and blood pressure is lowered.
Valsartan 40mg Capsules can be used for three different conditions:
• TO TREAT HIGH BLOOD PRESSURE IN CHILDREN AND ADOLESCENTS 6 TO 18
YEARS OF AGE. High blood pressure increases the workload on the
heart and arteries. If not treated it can damage the blood vessels
of the brain, heart, and kidneys, and may result in a stroke, heart
failure, or kidney failure. High blood pressure increases the risk of
heart attacks. Lowering your blood pressure to normal reduces the
risk of developing these disorders.
• TO TREAT ADULT PATIENTS AFTER A RECENT HEART ATTACK (myocardial
infarction). “Recent” here means between 12 hours and 10 days.

Карактеристике производа

OBJECT 1
VALSARTAN 80MG CAPSULES
Summary of Product Characteristics Updated 03-Mar-2016 | Accord-UK Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Valsartan 80mg Capsules
2. Qualitative and quantitative composition
Each capsule contains 80mg Valsartan.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Capsules, hard
Valsartan 80mg Capsules are a hard gelatin, light grey opaque / flesh
opaque capsule with 'VS2' over '
' on the cap and no markings on the body.
4. Clinical particulars
4.1 Therapeutic indications
Hypertension
Treatment of essential hypertension in adults, and hypertension in
children and adolescents 6 to 18 years
of age.
Recent myocardial infarction
Treatment of clinically stable adult patients with symptomatic heart
failure or asymptomatic left
ventricular systolic dysfunction after a recent (12 hours-10 days)
myocardial infarction (see sections 4.4
and 5.1)
Heart failure
Treatment of adult patients with symptomatic heart failure